IDEAYA Biosciences to Present at the 2022 Jefferies Global Healthcare Conference
IDEAYA Biosciences (NASDAQ: IDYA) announced its participation in the 2022 Jefferies Global Healthcare Conference on June 8, 2022, at 11:00 AM ET. CEO Yujiro Hata will engage in a fireside chat hosted by equity research analyst Maury Raycroft. A live audio webcast will be available on IDEAYA's website, with a replay accessible for 30 days post-event. IDEAYA focuses on precision medicine in oncology, targeting specific patient populations through molecular diagnostics and synthetic lethality.
- None.
- None.
SOUTH SAN FRANCISCO, Calif., June 8, 2022 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation at the 2022 Jefferies Global Healthcare Conference.
2022 Jefferies Global Healthcare Conference
Wednesday, June 8 at 11:00am ET
Fireside chat with Yujiro Hata, Chief Executive Officer, IDEAYA Biosciences, hosted by
Maury Raycroft, Ph.D. Equity Research Analyst, Biotechnology
A live audio webcast of the event will be available, as permitted by conference host, at the "Investors/News and Events/Investor Calendar" section of the IDEAYA website at https://ir.ideayabio.com/events. A replay of available webcasts will be accessible for 30 days following the live event.
IDEAYA is a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. IDEAYA's approach integrates capabilities in identifying and validating translational biomarkers with drug discovery to select patient populations most likely to benefit from its targeted therapies. IDEAYA is applying its early research and drug discovery capabilities to synthetic lethality – which represents an emerging class of precision medicine targets.
This press release contains forward-looking statements, including, but not limited to, statements related to participation in and/or presentation at certain investor relations events. IDEAYA undertakes no obligation to update or revise any forward-looking statements. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of IDEAYA in general, see IDEAYA's Quarterly Report on Form 10-Q filed on May 10, 2022 and any current and periodic reports filed with the U.S. Securities and Exchange Commission.
View original content to download multimedia:https://www.prnewswire.com/news-releases/ideaya-biosciences-to-present-at-the-2022-jefferies-global-healthcare-conference-301563339.html
SOURCE IDEAYA Biosciences, Inc.
FAQ
When will IDEAYA Biosciences participate in the 2022 Jefferies Global Healthcare Conference?
Who will represent IDEAYA Biosciences at the Jefferies Conference?
How can I access the IDEAYA Biosciences conference presentation?
Will there be a replay of IDEAYA's presentation at the Jefferies Conference?
What is IDEAYA Biosciences' focus in the oncology sector?
